• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3特斯拉扩散加权磁共振成像在评估肝纤维化中的价值。

Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis.

作者信息

Papalavrentios Lavrentios, Sinakos Emmanouil, Chourmouzi Danai, Hytiroglou Prodromos, Drevelegas Konstantinos, Constantinides Manos, Drevelegas Antonios, Talwalkar Jayant, Akriviadis Evangelos

机构信息

4 Internal Medicine Unit, University of Thessaloniki (Lavrentios Papalavrentios, Emmanouil Sinakos, Evangelos Akriviadis), Greece.

Department of Radiology, Interbalkan Medical Center, Thessaloniki (Danai Chourmouzi, Konstantinos Drevelegas, Manos Constantinides, Antonios Drevelegas), Greece.

出版信息

Ann Gastroenterol. 2015 Jan-Mar;28(1):118-123.

PMID:25608776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4289984/
Abstract

BACKGROUND

Limited data are available regarding the role of magnetic resonance imaging (MRI), particularly the new generation 3 Tesla technology, and especially diffusion-weighted imaging (DWI) in predicting liver fibrosis. The aim of our pilot study was to assess the clinical performance of the apparent diffusion coefficient (ADC) of liver parenchyma for the assessment of liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).

METHODS

18 patients with biopsy-proven NAFLD underwent DWI with 3 Tesla MRI. DWI was performed with single-shot echo-planar technique at b values of 0-500 and 0-1000 s/mm. ADC was measured in four locations in the liver and the mean ADC value was used for analysis. Staging of fibrosis was performed according to the METAVIR system.

RESULTS

The median age of patients was 52 years (range 23-73). The distribution of patients in different fibrosis stages was: 0 (n=1), 1 (n=7), 2 (n=1), 3 (n=5), 4 (n=4). Fibrosis stage was poorly associated with ADC at b value of 0-500 s/mm (r= -0.30, P=0.27). However it was significantly associated with ADC at b value of 0-1000 s/mm (r= -0.57, P=0.01). For this b value (0-1000 s/mm) the area under receiver-operating characteristic curve was 0.93 for fibrosis stage ≥3 and the optimal ADC cut-off value was 1.16 ×10 mm/s.

CONCLUSION

3 Tesla DWI can possibly predict the presence of advanced fibrosis in patients with NAFLD.

摘要

背景

关于磁共振成像(MRI),尤其是新一代3特斯拉技术,特别是扩散加权成像(DWI)在预测肝纤维化中的作用,现有数据有限。我们的初步研究目的是评估肝实质表观扩散系数(ADC)在非酒精性脂肪性肝病(NAFLD)患者肝纤维化评估中的临床性能。

方法

18例经活检证实为NAFLD的患者接受了3特斯拉MRI的DWI检查。采用单次激发回波平面技术在b值为0 - 500和0 - 1000 s/mm²时进行DWI检查。在肝脏的四个位置测量ADC,并使用平均ADC值进行分析。根据METAVIR系统进行纤维化分期。

结果

患者的中位年龄为52岁(范围23 - 73岁)。不同纤维化阶段患者的分布为:0期(n = 1),1期(n = 7),2期(n = 1),3期(n = 5),4期(n = 4)。在b值为0 - 500 s/mm²时,纤维化阶段与ADC的相关性较差(r = -0.30,P = 0.27)。然而,在b值为0 - 1000 s/mm²时,它与ADC显著相关(r = -0.57,P = 0.01)。对于该b值(0 - 1000 s/mm²),纤维化阶段≥3时的受试者操作特征曲线下面积为0.93,最佳ADC临界值为1.16×10⁻³ mm²/s。

结论

3特斯拉DWI可能有助于预测NAFLD患者是否存在晚期纤维化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f0/4289984/e5b921c8dc26/AOG-28-118-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f0/4289984/be148397d2e4/AOG-28-118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f0/4289984/a076bb0c6ef2/AOG-28-118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f0/4289984/e5b921c8dc26/AOG-28-118-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f0/4289984/be148397d2e4/AOG-28-118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f0/4289984/a076bb0c6ef2/AOG-28-118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f0/4289984/e5b921c8dc26/AOG-28-118-g004.jpg

相似文献

1
Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis.3特斯拉扩散加权磁共振成像在评估肝纤维化中的价值。
Ann Gastroenterol. 2015 Jan-Mar;28(1):118-123.
2
[Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].[肝脏纤维化临床与病理变化的磁共振扩散加权成像对比研究]
Zhonghua Yi Xue Za Zhi. 2009 Jul 7;89(25):1757-61.
3
Magnetic resonance-based total liver volume and magnetic resonance-diffusion weighted imaging for staging liver fibrosis in mini-pigs.基于磁共振的全肝体积和磁共振弥散加权成像在小型猪肝纤维化分期中的应用。
World J Gastroenterol. 2012 Dec 28;18(48):7225-33. doi: 10.3748/wjg.v18.i48.7225.
4
Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.弥散加权 MRI 评估肝纤维化和肝硬化的价值。
AJR Am J Roentgenol. 2009 Dec;193(6):1556-60. doi: 10.2214/AJR.09.2436.
5
Diffusion-weighted magnetic resonance imaging for the assessment of liver fibrosis in chronic viral hepatitis.弥散加权磁共振成像在慢性病毒性肝炎肝纤维化评估中的应用。
PLoS One. 2021 Mar 4;16(3):e0248024. doi: 10.1371/journal.pone.0248024. eCollection 2021.
6
Feasibility of diagnosing and staging liver fibrosis with diffusion weighted imaging.利用扩散加权成像诊断肝纤维化及进行分期的可行性
Chin Med Sci J. 2008 Sep;23(3):183-6. doi: 10.1016/s1001-9294(09)60036-5.
7
Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients.扩散加权磁共振成像在评估肝纤维化中的应用:肝硬化患者的可行性研究
Radiol Med. 2007 Apr;112(3):394-408. doi: 10.1007/s11547-007-0149-1. Epub 2007 Apr 20.
8
Assessment of Liver Fibrosis with Diffusion-Weighted Magnetic Resonance Imaging Using Different b-values in Chronic Viral Hepatitis.在慢性病毒性肝炎中使用不同b值的扩散加权磁共振成像评估肝纤维化
Med Princ Pract. 2015;24(6):522-6. doi: 10.1159/000434682. Epub 2015 Jul 16.
9
Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?脂肪变性是否会影响丙型肝炎病毒4型慢性肝炎患者扩散加权磁共振成像值在纤维化评估中的表现?
Turk J Gastroenterol. 2017 Jul;28(4):283-288. doi: 10.5152/tjg.2017.16640. Epub 2017 Jun 7.
10
Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.磁共振扩散加权成像的诊断价值:身体不同区域良恶性淋巴结的鉴别
Clin Imaging. 2015 Sep-Oct;39(5):856-62. doi: 10.1016/j.clinimag.2015.05.006. Epub 2015 May 22.

引用本文的文献

1
Correlation analysis of the abdominal visceral fat area with the structure and function of the heart and liver in obesity: a prospective magnetic resonance imaging study.肥胖患者腹部内脏脂肪面积与心脏和肝脏结构及功能的相关性分析:一项前瞻性磁共振成像研究。
Cardiovasc Diabetol. 2023 Aug 10;22(1):206. doi: 10.1186/s12933-023-01926-0.
2
Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis.综合概述:用于检测和测量肝纤维化的成熟及新兴磁共振成像技术
Pediatr Radiol. 2018 Aug;48(9):1256-1272. doi: 10.1007/s00247-018-4083-2. Epub 2018 Aug 4.
3
3.0 Tesla magnetic resonance imaging: A new standard in liver imaging?

本文引用的文献

1
Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value.用于肝纤维化的扩散加权磁共振成像:b值的影响
Iran J Radiol. 2014 Jan;11(1):e3555. doi: 10.5812/iranjradiol.3555. Epub 2014 Jan 30.
2
Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI.利用扩散加权肝脏磁共振成像中的体素内不相干运动评估肝纤维化
J Comput Assist Tomogr. 2014 Jan-Feb;38(1):110-6. doi: 10.1097/RCT.0b013e3182a589be.
3
3 Tesla diffusion-weighted MRI for assessing liver fibrosis in nonalcoholic fatty liver disease.
3.0特斯拉磁共振成像:肝脏成像的新标准?
World J Hepatol. 2015 Jul 28;7(15):1894-8. doi: 10.4254/wjh.v7.i15.1894.
3特斯拉扩散加权磁共振成像用于评估非酒精性脂肪性肝病中的肝纤维化
Hepatology. 2013 Jul;58(1):449-50. doi: 10.1002/hep.26220.
4
Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation.常规弥散加权成像和弥散张量成像对肝纤维化和炎症的诊断性能。
Eur J Radiol. 2013 Feb;82(2):203-7. doi: 10.1016/j.ejrad.2012.09.009. Epub 2012 Nov 2.
5
Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis.磁共振弹性成像和弥散加权成像在肝纤维化分期中的性能:一项荟萃分析。
Hepatology. 2012 Jul;56(1):239-47. doi: 10.1002/hep.25610. Epub 2012 Jun 6.
6
Utility of diffusion-weighted imaging in the evaluation of liver fibrosis.弥散加权成像在肝纤维化评估中的应用。
Eur Radiol. 2012 Mar;22(3):682-7. doi: 10.1007/s00330-011-2295-z. Epub 2011 Oct 9.
7
Diffusion-weighted imaging of the breast: principles and clinical applications.乳腺扩散加权成像:原理与临床应用。
Radiographics. 2011 Jul-Aug;31(4):1059-84. doi: 10.1148/rg.314105160.
8
Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis.弥散加权磁共振成像在肝纤维化分期中的应用。
J Clin Gastroenterol. 2011 Nov-Dec;45(10):885-92. doi: 10.1097/MCG.0b013e318223bd2c.
9
Diffusion weighted imaging in the liver.肝脏弥散加权成像。
World J Gastroenterol. 2010 Apr 7;16(13):1567-76. doi: 10.3748/wjg.v16.i13.1567.
10
Use of 3.0-T MR imaging for evaluation of the abdomen.使用 3.0T MR 成像评估腹部。
Radiographics. 2009 Oct;29(6):1547-63. doi: 10.1148/rg.296095516.